Articles tagged: Biotech
Ann Arbor biotech company AlphaCore acquired by multi-national pharmaceutical corporation AstraZeneca
Posted: Apr 03, 2013The biologics division of Chicago-based multinational pharmaceutical company AstraZeneca purchased Ann Arbor-based biotechnology company AlphaCore Wednesday. Read more »
Ann Arbor biotech company Lycera makes a second $300 million deal with Merck
Posted: Feb 13, 2013Ann Arbor biotechnology company Lycera announced a collaboration with pharmaceutical giant Merck on Tuesday that could be worth more than $300 million. Read more »
NanoBio raises $11 million in new round of funding
Posted: Nov 29, 2012With the closing of an $11 million Series C funding round, Ann Arbor-based biotechnology company NanoBio has now raised more than $130 million in funding. The company was founded in 2000 as a University of ... Read more »
Calvin Magee mostly mum on winged helmets, talks Michigan football quarterbacks
Posted: Aug 18, 2010Michigan football offensive coordinator Calvin Magee kept quiet Wednesday afternoon when asked if Wolverines quarterback Tate Forcier had earned back his wings yet. "I won't tell you that," Magee said, before adding, "I have mine." ... Read more »
On-the-go snack ideas that are healthy (and taste good, too)
Posted: Jul 02, 2010Eating healthy on the go is a challenge requiring good planning and creative ideas and snacks are an important part of daily healthy meal plans. Keep these healthy snacks in mind when your at the ... Read more »
AnnArbor.com launches page of news devoted to Saline
Posted: May 27, 2010Since our launch 10 months ago, AnnArbor.com has worked to expand our coverage area and bring you stories not just from Ann Arbor, but from surrounding communities as well. One of our top priorities is ... Read more »
Former Michigan players unhappy with losing, hoping for a turnaround in 2010
Posted: May 16, 2010Marlin Jackson has taken some ribbing from his NFL teammates over Michigan’s 8-16 record the last two years. It’s been good-natured and fun-loving, but hard to swallow nonetheless. “I don’t know where we’re headed,” Jackson ... Read more »
Ann Arbor biotech firm NanoBio awarded critical patent
Posted: Feb 02, 2010Ann Arbor-based biotechnology firm NanoBio Corp. has received a U.S. patent that solidifies intellectual property rights considered key to its top products, the company announced today. NanoBio, a University of Michigan spinoff firm, was awarded ... Read more »
University of Michigan spinoff Lycera hires CEO, shifts headquarters to Massachusetts
Posted: Jan 07, 2010University of Michigan spinoff biotech firm Lycera Corp. has hired a CEO and is shifting its official headquarters to Massachusetts, where the new executive lives. Lycera hired Boston area pharmaceutical industry veteran William J. Sibold ... Read more »
Esperion Therapeutics veteran Timothy Mayleben becomes CEO of Aastrom Biosciences
Posted: Dec 20, 2009Timothy Mayleben is endowed with the Esperion Therapeutics mystique. Whether that helps him rescue Ann Arbor-based biotechnology firm Aastrom Biosciences is to be determined. Mayleben, a longtime Aastrom board member, became CEO last week after ... Read more »
Ann Arbor's NanoBio strikes multimillion-dollar licensing deal with GlaxoSmithKline
Posted: Dec 16, 2009Ann Arbor-based NanoBio Corp. announced today that it's signed an agreement with United Kingdom-based pharmaceutical giant GlaxoSmithKline to license its cold sore treatment still in clinical development. The deal provides $14.5 million upfront to NanoBio in ... Read more »
Biotech company update: $275M sale finalized for Ann Arbor's HandyLab
Posted: Nov 20, 2009The deal for Ann Arbor medical devices firm HandyLab, a promising technology company often held up as a bright spot in the local economy, has been finalized by New Jersey-based medical devices manufacturer Becton, Dickinson ... Read more »
Aastrom Biosciences launching Phase 2 clinical trial
Posted: Nov 10, 2009Ann Arbor-based Aastrom Biosciences is launching another Phase 2 clinical trial to study the effectiveness of its cell treatment for a disease that causes chronic heart failure. The clinical trial will examine whether Aastrom’s cardiac ... Read more »
HandyLab acquisition paves way for 'future expansions,' executive says
Posted: Nov 04, 2009The global medical devices company that’s acquiring Ann Arbor-based HandyLab expects to leverage the opportunity to expand into new markets, executives said today. New Jersey-based Becton, Dickinson and Co., which announced Oct. 23 that it ... Read more »
Get the Ann Arbor RSS Feed
AnnArbor.com